Skip to main navigation Skip to search Skip to main content

Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme

  • Dragana Bugarski-Kirola
  • , Nakao Iwata
  • , Snjezana Sameljak
  • , Carol Reid
  • , Thomas Blaettler
  • , Laurie Millar
  • , Tiago Reis Marques
  • , George Garibaldi
  • , Shitij Kapur

Research output: Contribution to journal › Article › peer-review

91   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases